Poly(adp-ribose) polymerase inhibitor

Intervention

1 paper1 finding

  • 1 lab in 1 country
  • Human trial1

Outcomes

1

Putative CH TP53 variants

upin humans1

1 study
  1. Poly(adp-ribose) polymerase inhibitor increases putative CH TP53 variants in humans (0/8 to 6/8 patients).

    Humansfirst-line platinum followed by PARP inhibitor maintenanceplasma cfDNAduring B2-B3femalesn = 8

    cfDNA-inferred putative clonal hematopoiesis during first-line platinum-to-PARP inhibitor maintenance in ovarian cancer

    Journal of gynecologic oncology27 Jul 2026

More on Putative CH TP53 variants

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 01 in 12 months